0001415889-24-007527.txt : 20240311 0001415889-24-007527.hdr.sgml : 20240311 20240311171732 ACCESSION NUMBER: 0001415889-24-007527 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240308 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dierks Jeffrey CENTRAL INDEX KEY: 0001821102 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39450 FILM NUMBER: 24739134 MAIL ADDRESS: STREET 1: 630 W. GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc. CENTRAL INDEX KEY: 0001802665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822279923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: (484) 539-9800 MAIL ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 4 1 form4-03112024_090322.xml X0508 4 2024-03-08 0001802665 Harmony Biosciences Holdings, Inc. HRMY 0001821102 Dierks Jeffrey C/O HARMONY BIOSCIENCES HOLDINGS, INC. 630 W GERMANTOWN PIKE, SUITE 215 PLYMOUTH MEETING PA 19462 false true false false CHIEF COMMERCIAL OFFICER 0 Common Stock 2024-03-08 4 M 0 194 8.22 A 194 D Common Stock 2024-03-08 4 S 0 194 32 D 0 D Stock Option 8.22 2024-03-08 4 M 0 100 0 D 2029-10-01 Common Stock 100 2335 D Stock Option 8.22 2024-03-08 4 M 0 94 0 D 2030-03-04 Common Stock 94 14513 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. These shares were sold in a single transaction at a selling price of $32.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock option vests in five equal annual installments beginning on October 1, 2019. The stock option vests in five equal annual installments beginning on March 1, 2021. /s/ Christian Ulrich, Attorney-in-Fact 2024-03-11